Hit enter to search or ESC to close

Recent Grants Related to MERS

admin

To help academic community quickly catch up on the most recent research grants awarded by US government, Paper Digest Team extracted all grants related to MERS on our radar (including old grants related to this topic). These results are sorted by relevance & date and will be updated on a weekly basis.

If you do not want to miss interesting academic papers, you are welcome to sign up our free service to get a one sentence summary of each new paper published in your area on a daily basis. You will also have access to our console that allows you to search for papers, patents, and grants. You are welcome to follow us on Twitter and Linkedin to get updated with new conference digests.

Paper Digest Team
New York City, New York, 10017
team@paperdigest.org

TABLE 1: Recent Grants Related to MERS

Project PI(s) Organization Start
1 “Cell entry, cross-species transmission and pathogenesis of novel coronavirus from” RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2024-08-09
2 Cell competition in pulmonary fibrosis and ARDS STIJN PIET JOHAN DE LANGHE MAYO CLINIC ROCHESTER 2024-08-09
3 Emerging Infectious Diseases Research Center – East and Central Africa M KARIUKI NJENGA WASHINGTON STATE UNIVERSITY 2024-07-22
4 Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic Potential KYEONG-OK CHANG KANSAS STATE UNIVERSITY 2024-07-19
5 Project 3: SARS CoV-2 Lung Organoid Interactions in Replication and Pathogenesis RALPH S BARIC STANFORD UNIVERSITY 2024-03-15
6 Functional Viromics of Betacoronavirus Entry MICHAEL LETKO WASHINGTON STATE UNIVERSITY 2023-11-16
7 Emerging Infectious Diseases Research Center – East and Central Africa M KARIUKI NJENGA WASHINGTON STATE UNIVERSITY 2023-08-24
8 Cell competition in pulmonary fibrosis and ARDS STIJN PIET JOHAN DE LANGHE MAYO CLINIC ROCHESTER 2023-08-23
9 “Cell entry, cross-species transmission and pathogenesis of novel coronavirus from” RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2023-08-21
10 West African Emerging Infectious Disease Research Center (WA-EIDRC) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE, THE 2023-08-16
11 Human coronavirus infection of the nasal epithelium SUSAN R WEISS UNIVERSITY OF PENNSYLVANIA 2023-07-12
12 Multidimensional antibody engineering to enhance the potency and breadth of a betacoronavirus medical countermeasure ZACHARY A BORNHOLDT EITR BIOLOGICS, INC. 2023-06-26
13 Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2 KYEONG-OK CHANG KANSAS STATE UNIVERSITY 2023-05-26
14 Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals JUN WANG RUTGERS BIOMEDICAL AND HEALTH SCIENCES 2023-05-26
15 Project 1: Panbetacoronavirus vaccines BARTON F. HAYNES DUKE UNIVERSITY 2023-05-26
16 Role of Diabetes in MERS Coronavirus Pathogenesis MATTHEW BRYAN FRIEMAN UNIVERSITY OF MARYLAND BALTIMORE 2023-05-24
17 Project 3: SARS CoV-2 Lung Organoid Interactions in Replication and Pathogenesis RALPH S BARIC STANFORD UNIVERSITY 2023-03-23
18 Interplay between coronaviruses and nonsense-mediated mRNA decay pathway SHINJI MAKINO UNIVERSITY OF TEXAS MED BR GALVESTON 2023-03-03
19 Coronavirus Genome Replication CRAIG E. CAMERON UNIV OF NORTH CAROLINA CHAPEL HILL 2023-02-24
20 Structural vaccinology guided development of a universal CoV vaccine utilizing nucleic acid delivered nanoparticles DAVID B. WEINER WISTAR INSTITUTE 2022-09-22
21 Human coronavirus infection of the nasal epithelium SUSAN R WEISS UNIVERSITY OF PENNSYLVANIA 2022-09-20
22 Project 1: Serological Correlates of SARS CoV2 Immunity and Disease RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2022-09-19
23 Core B: Virology Core RALPH S BARIC UNIVERSITY OF WASHINGTON 2022-09-02
24 Cell competition in pulmonary fibrosis and ARDS STIJN PIET JOHAN DE LANGHE MAYO CLINIC ROCHESTER 2022-08-19
25 “Cell entry, cross-species transmission and pathogenesis of novel coronavirus from” RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2022-08-18
26 Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2 KYEONG-OK CHANG KANSAS STATE UNIVERSITY 2022-07-22
27 Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity CHRISTOPHER F BASLER ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2022-07-08
28 Role of Diabetes in MERS Coronavirus Pathogenesis MATTHEW BRYAN FRIEMAN UNIVERSITY OF MARYLAND BALTIMORE 2022-06-17
29 Emerging Infectious Diseases Research Center – East and Central Africa M KARIUKI NJENGA WASHINGTON STATE UNIVERSITY 2022-06-17
30 Miniature passive thermal control valve for mixing or splitting single-phase fluid MITAL MISTRY KALSI ENGINEERING, INCORPORATED 2022-05-31
31 Small Molecule Protease Inhibitors against MERS-CoV KYEONG-OK CHANG KANSAS STATE UNIVERSITY 2022-05-03
32 Project 3: SARS CoV-2 Lung Organoid Interactions in Replication and Pathogenesis RALPH S BARIC STANFORD UNIVERSITY 2022-04-27
33 Interplay between coronaviruses and nonsense-mediated mRNA decay pathway SHINJI MAKINO UNIVERSITY OF TEXAS MED BR GALVESTON 2022-04-27
34 Determinants of Coronavirus Fidelity in Replication and Pathogenesis MARK R. DENISON VANDERBILT UNIVERSITY MEDICAL CENTER 2022-04-27
35 MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins SUSAN R WEISS UNIVERSITY OF PENNSYLVANIA 2022-04-22
36 Miniature High Resolution Planetary X-ray Diffraction Instrument PHILIPPE SARRAZIN EXAMINART, LLC 2022-04-13
37 Collaborative Research: Transport of model-virus through the lung liquid lining JUAN LOPEZ; ARIZONA STATE UNIVERSITY 2022-04-01
38 Collaborative Research: Transport of model-virus through the lung liquid lining AMIR HIRSA; RENSSELAER POLYTECHNIC INSTITUTE 2022-04-01
39 Coronavirus Genome Replication CRAIG E. CAMERON UNIV OF NORTH CAROLINA CHAPEL HILL 2022-03-04
40 Determinants of Coronavirus Fidelity in Replication and Pathogenesis MARK R. DENISON VANDERBILT UNIVERSITY MEDICAL CENTER 2022-02-24
41 Forum on Microbial Threats JULIE LIAO NATIONAL ACADEMY OF SCIENCES 2022-02-07
42 Regional Biocontainment Laboratory (RBL) Upgrade for Colorado State University (CSU) KAREN MARIE DOBOS COLORADO STATE UNIVERSITY 2021-09-23
43 Project 1: Panbetacoronavirus vaccines BARTON F. HAYNES DUKE UNIVERSITY 2021-09-16
44 Emerging Infectious Diseases Research Center – East and Central Africa M KARIUKI NJENGA WASHINGTON STATE UNIVERSITY 2021-09-10
45 Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2021-08-26
46 Structural and functional analysis of the coronavirus spike protein fusion peptide SUSAN DANIEL CORNELL UNIVERSITY 2021-08-17
47 Cell entry, cross-species transmission and pathogenesis of novel coronavirus from Wuhan RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2021-08-13
48 Dissecting the role of the coronavirus proofreading exoribonuclease in RNA recombination JENNIFER GRIBBLE VANDERBILT UNIVERSITY 2021-08-11
49 Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2 KYEONG-OK CHANG KANSAS STATE UNIVERSITY 2021-08-06
50 Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals JUN WANG UNIVERSITY OF ARIZONA 2021-07-28
51 PPG: SARS-CoV-host cell interactions and vaccine development STANLEY PERLMAN UNIVERSITY OF IOWA 2021-07-23
52 Structural and functional analysis of the coronavirus spike protein fusion peptide SUSAN DANIEL CORNELL UNIVERSITY 2021-07-23
53 Adaptive MERS coronavirus-cell entry pathways and their relevance to virulence and antiviral strategies THOMAS MILLER GALLAGHER UNIVERSITY OF IOWA 2021-07-23
54 Project 1 STANLEY PERLMAN UNIVERSITY OF IOWA 2021-07-23
55 Project-003 PAUL B MCCRAY UNIVERSITY OF IOWA 2021-07-23
56 Exploring the Coronavirus Exoribonuclease as an Antiviral Target SANDRA K WELLER UNIVERSITY OF CONNECTICUT SCH OF MED/DNT 2021-07-19
57 Rational design and evaluation of novel mRNA vaccines against MERS-CoV LANYING DU GEORGIA STATE UNIVERSITY 2021-07-15
58 Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity CHRISTOPHER F BASLER GEORGIA STATE UNIVERSITY 2021-06-25
59 Emerging Infectious Diseases Research Center – East and Central Africa M KARIUKI NJENGA WASHINGTON STATE UNIVERSITY 2021-06-11
60 Role of Diabetes in MERS Coronavirus Pathogenesis MATTHEW BRYAN FRIEMAN UNIVERSITY OF MARYLAND BALTIMORE 2021-06-03
61 Miniature High Resolution Planetary X-ray Diffraction Instrument PHILIPPE SARRAZIN EXAMINART, LLC 2021-05-10
62 Miniature passive thermal control valve for mixing or splitting single-phase fluid MITAL MISTRY KALSI ENGINEERING, INCORPORATED 2021-05-10
63 MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins SUSAN R WEISS UNIVERSITY OF PENNSYLVANIA 2021-04-27
64 MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins SUSAN R WEISS UNIVERSITY OF PENNSYLVANIA 2021-04-22
65 Small Molecule Protease Inhibitors against MERS-CoV KYEONG-OK CHANG KANSAS STATE UNIVERSITY 2021-04-22
66 Project 3: SARS CoV-2 Lung Organoid Interactions in Replication and Pathogenesis RALPH S BARIC STANFORD UNIVERSITY 2021-04-13
67 Determinants of Coronavirus Fidelity in Replication and Pathogenesis RALPH S BARIC VANDERBILT UNIVERSITY MEDICAL CENTER 2021-03-25
68 Determinants of Coronavirus Fidelity in Replication and Pathogenesis RALPH S BARIC VANDERBILT UNIVERSITY MEDICAL CENTER 2021-03-17
69 Coronavirus Genome Replication JAMIE JON ARNOLD UNIV OF NORTH CAROLINA CHAPEL HILL 2021-03-15
70 Exploring alternate targets for inhibition of virus infection by PPI disruption MICHAEL A CALDERWOOD DANA-FARBER CANCER INST 2021-02-19
71 Rational design and evaluation of novel mRNA vaccines against MERS-CoV LANYING DU NEW YORK BLOOD CENTER 2021-01-27
72 Forum on Microbial Threats JULIE PAVLIN NATIONAL ACADEMY OF SCIENCES 2021-01-14
73 CAREER: Big Computation and the Management of Emerging Infectious Diseases ERIC LABER; DUKE UNIVERSITY 2021-01-01
74 Cell entry, cross-species transmission and pathogenesis of novel coronavirus from Wuhan RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2020-09-25
75 Project 1: Serological Correlates of SARS CoV2 Immunity and Disease RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2020-09-22
76 Mathematical and Statistical Methods for the Control of Global Infectious Disease Threats M ELIZABETH HALLORAN UNIVERSITY OF FLORIDA 2020-09-04
77 Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2020-08-28
78 Dissecting the role of the coronavirus proofreading exoribonuclease in RNA recombination JENNIFER GRIBBLE VANDERBILT UNIVERSITY 2020-08-19
79 Role of eicosanoids in pathogenic human CoV infections STANLEY PERLMAN UNIVERSITY OF IOWA 2020-08-07
80 Project 1 STANLEY PERLMAN UNIVERSITY OF IOWA 2020-08-05
81 Adaptive MERS coronavirus-cell entry pathways and their relevance to virulence and antiviral strategies THOMAS MILLER GALLAGHER UNIVERSITY OF IOWA 2020-08-05
82 PPG: SARS-CoV-host cell interactions and vaccine development STANLEY PERLMAN UNIVERSITY OF IOWA 2020-08-05
83 Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2020-08-04
84 Structural and functional analysis of the coronavirus spike protein fusion peptide SUSAN DANIEL CORNELL UNIVERSITY 2020-07-27
85 Structural and functional analysis of the coronavirus spike protein fusion peptide SUSAN DANIEL CORNELL UNIVERSITY 2020-07-22
86 Toward a protective Covid-19 vaccine utilizing an established vector platform MATTHIAS JOHANNES SCHNELL THOMAS JEFFERSON UNIVERSITY 2020-07-16
87 Clinical evaluation of SARS-CoV-2 subunit vaccine in a Phase I human clinical study GRACE M ALDROVANDI UNIVERSITY OF CALIFORNIA LOS ANGELES 2020-07-15
88 Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination LANYING DU NEW YORK BLOOD CENTER 2020-07-13
89 How MERS-CoV Regulates Immunity in Human Lung Tissue TIMOTHY PATRICK SHEAHAN BATTELLE PACIFIC NORTHWEST LABORATORIES 2020-07-06
90 RAPID: Changes in risk perceptions and COVID-19 ABRAM WAGNER; SHU-FANG SHIH; REGENTS OF THE UNIVERSITY OF MICHIGAN – ANN ARBOR 2020-07-01
91 Hawaii Biotech COVID-19 Response to PA-18-591 DAVID E. CLEMENTS HAWAII BIOTECH, INC. 2020-06-24
92 Role of Diabetes in MERS Coronavirus Pathogenesis MATTHEW BRYAN FRIEMAN UNIVERSITY OF MARYLAND BALTIMORE 2020-06-16
93 RAPID: Molecular Insights into the SARS-CoV-2 Spike Protein Activation via a Novel Interaction with a Human Cell Surface Target Protein TINA IZARD; THE SCRIPPS RESEARCH INSTITUTE 2020-06-15
94 EAGER: Investigation of host and viral factors that influence the severity of coronaviral disease JAMES MACY; CARMEN BOOTH; SUSAN COMPTON; SUSAN COMPTON; YALE UNIVERSITY 2020-06-01
95 RAPID: IIBR: Coronavirus Viroporin XFEL Structural Studies BRENDA HOGUE; ARIZONA STATE UNIVERSITY 2020-06-01
96 Emerging Infectious Diseases Research Center – East and Central Africa M KARIUKI NJENGA WASHINGTON STATE UNIVERSITY 2020-05-26
97 SARS-CoV-2 polymerase inhibitor screening BAEK KIM EMORY UNIVERSITY 2020-05-18
98 Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation TREVOR BC BEDFORD FRED HUTCHINSON CANCER RESEARCH CENTER 2020-05-12
99 Mechanistic understanding and inhibition of Zika NS5 protein RONG HAI UNIVERSITY OF CALIFORNIA RIVERSIDE 2020-05-11
100 How MERS-CoV Regulates Innate Immunity in Primary Human Lung Cells TIMOTHY PATRICK SHEAHAN UNIV OF NORTH CAROLINA CHAPEL HILL 2020-05-11
101 Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2020-05-08
102 MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins SUSAN R WEISS UNIVERSITY OF PENNSYLVANIA 2020-04-22
103 MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins SUSAN R WEISS UNIVERSITY OF PENNSYLVANIA 2020-04-13
104 Small Molecule Protease Inhibitors against MERS-CoV KYEONG-OK CHANG KANSAS STATE UNIVERSITY 2020-04-08
105 Role of DPP4-ADA interaction in obesity-induced inflammation JIXIN ZHONG CASE WESTERN RESERVE UNIVERSITY 2020-04-07
106 RAPID: On-mask Chemical Modulation of Respiratory Droplets JIAXING HUANG; NORTHWESTERN UNIVERSITY 2020-04-01
107 Interplay between coronaviruses and nonsense-mediated mRNA decay pathway SHINJI MAKINO UNIVERSITY OF TEXAS MED BR GALVESTON 2020-03-11
108 Development of a safe and effective RBD-based vaccine against MERS-CoV PETER J HOTEZ BAYLOR COLLEGE OF MEDICINE 2020-03-11
109 A novel and effective nanobody to prevent and treat Zika virus infection LANYING DU NEW YORK BLOOD CENTER 2020-03-02
110 Determinants of Coronavirus Fidelity in Replication and Pathogenesis RALPH S BARIC VANDERBILT UNIVERSITY MEDICAL CENTER 2020-02-11
111 Forum on Microbial Threats CECILIA MUNDACA SHAH NATIONAL ACADEMY OF SCIENCES 2020-01-27
112 Rational design and evaluation of novel mRNA vaccines against MERS-CoV LANYING DU NEW YORK BLOOD CENTER 2020-01-21